Journal for ImmunoTherapy of Cancer (Feb 2022)
Neoantigens as potential vaccines in hepatocellular carcinoma
- Kathrin Heim,
- Maike Hofmann,
- Robert Thimme,
- Marta Ruiz,
- Pablo Sarobe,
- Sandra Hervás-Stubbs,
- Bruno Sangro,
- Luigi Buonaguro,
- Beatrice Cavalluzzo,
- Angela Mauriello,
- Maria Tagliamonte,
- David Repáraz,
- Enric Vercher,
- Diana Llopiz,
- Leyre Silva,
- Belén Aparicio,
- Josune Egea,
- Ibon Tamayo-Uria,
- Jorge García-Balduz,
- Carla Castro,
- Mercedes Iñarrairaegui,
- Charlotte Rohrer,
- Catrin Tauber
Affiliations
- Kathrin Heim
- Internal Medicine II, Faculty of Medicine, Freiburg University Hospital, Freiburg, Germany
- Maike Hofmann
- Department of Medicine II, University Hospital Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Robert Thimme
- 4 Department of Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Medical Center, University of Freiburg, Freiburg, Germany
- Marta Ruiz
- 1 Department of Neurosciences (DNS), University of Padova, Padova, Italy
- Pablo Sarobe
- 1 Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain
- Sandra Hervás-Stubbs
- Programa de Inmunología e Inmunoterapia, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Bruno Sangro
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Luigi Buonaguro
- Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy
- Beatrice Cavalluzzo
- Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy
- Angela Mauriello
- Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy
- Maria Tagliamonte
- Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy
- David Repáraz
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Enric Vercher
- Programa de Inmunología e Inmunoterapia, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Diana Llopiz
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Leyre Silva
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Belén Aparicio
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Josune Egea
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Ibon Tamayo-Uria
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Jorge García-Balduz
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Carla Castro
- Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
- Mercedes Iñarrairaegui
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain
- Charlotte Rohrer
- Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Catrin Tauber
- Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- DOI
- https://doi.org/10.1136/jitc-2021-003978
- Journal volume & issue
-
Vol. 10,
no. 2
Abstract
No abstracts available.